Trump's Drug Price Website Offers Deep Discounts, But Most Americans Won't Benefit

Paying cash for prescription drugs — even at a discount of up to 93% — won’t count toward your insurance deductible or out-of-pocket maximum. That means for most Americans with health coverage, using TrumpRx.gov may save money in the moment but delay access to full insurance benefits later. The site, launched by former President Donald Trump, offers price comparisons for 43 medications purchased directly from 16 drug manufacturers. But if your drug isn’t on the list, or you’re counting on meeting your deductible, the deal quickly loses value. Approximately 68% of Americans take prescription drugs regularly, and 8% skip doses due to cost. For the 17.9% of Americans under 65 without insurance, TrumpRx could offer real relief — assuming their medication is among the 43 covered. But for the majority with insurance, the structural flaw is decisive: the transaction doesn’t register with their insurer. George Chapman, a retired hospital consultant, calls the program unlikely to help many. He notes that Congress banned Medicare from negotiating drug prices in 2003 — a concession to drug companies when Part D was created. The Inflation Reduction Act only reversed that partially, allowing negotiation for 15 drugs a year. Meanwhile, the U.S., with 5% of the world’s population, buys half of all prescription drugs, subsidizing global R&D. Prices remain opaque, pharmacy benefit managers deliver minimal savings, and Congress has refused to impose price transparency. TrumpRx highlights the dysfunction — but doesn’t fix it.